Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis

Background  In order to relieve the financial burden of the patients in China, the Ministry of Health (MoH) conducted the first national price negotiation and successfully negotiated three expensive medicines including 2 targeted anticancer medicines (TAMs), icotinib and gefitinib. However, little e...

Full description

Saved in:
Bibliographic Details
Main Authors: Cong Huang (Author), Carolina Ung (Author), Haishaerjiang Wushouer (Author), Lin Bai (Author), Xinyi Li (Author), Xiaodong Guan (Author), Luwen Shi (Author)
Format: Book
Published: Kerman University of Medical Sciences, 2022-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!